Understanding Neurodiversity Neurodivergence is often mistakenly equated solely with autism. As Prof. Kirby explains, it is a ...

Shionogi has dosed the first patients in the phase 2 clinical trial evaluating S-606001, a potential treatment for late-onset ...

Clasado Biosciences has appointed Sebastian Nummelin as APAC Regional Director. The move strengthens its commercial presence ...

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that ...

CNX Therapeutics has appointed David Flint as Chief Corporate Development Officer (CCDO). Flint is an experienced M&A and ...

Bladder cancer affects over 224,000 people annually in Europe, with over 30% of cases being muscle-invasive bladder cancer ...

Raguneprocel, a stem cell-based dopamine neuron replacement therapy for treating motor symptoms in Parkinson’s disease (PD), ...

Allergan Aesthetics, an AbbVie company, has launched a unified vocabulary to standardise how skin quality is discussed. The ...

AC Immune has entered into an agreement with Eli Lilly (Lilly) to amend their 2018 licence and collaboration agreement to ...

There will be clear winners and losers across global stock markets should the US and Iran reach a peace deal this weekend, ...

The European Medicines Agency (EMA) has launched three major new features for PRIME, a scheme supporting the development of ...

Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient ...